View in EDS

Long‐Term Efficacy and Safety of Ligelizumab as Re‐Treatment in Patients With Chronic Spontaneous Urticaria.

Saved in:
Bibliographic Details
Title: Long‐Term Efficacy and Safety of Ligelizumab as Re‐Treatment in Patients With Chronic Spontaneous Urticaria.
Authors: Gimenez‐Arnau, Ana M.1 (AUTHOR) anamariagimenezarnau@gmail.com, Maurer, Marcus2,3 (AUTHOR), Reich, Adam4 (AUTHOR), Chu, Chia‐Yu5 (AUTHOR), Deleanu, Diana6 (AUTHOR), Sussman, Gordon7 (AUTHOR), Sanchez, Jorge8 (AUTHOR), Brockow, Knut9 (AUTHOR), Hayama, Koremasa10 (AUTHOR), Hide, Michihiro11,12 (AUTHOR), Denguezli, Mohamed13 (AUTHOR), Meshkova, Raisa14 (AUTHOR), Criado, Roberta F. J.15 (AUTHOR), Saini, Sarbjit16 (AUTHOR), Valle, Solange17 (AUTHOR), Hua, Eva18 (AUTHOR), Wang, Pengpeng18 (AUTHOR), Burciu, Alis19 (AUTHOR), Indermuehle, Isabelle19 (AUTHOR), Varanasi, Vineeth20 (AUTHOR)
Source: Allergy. Jul2026, Vol. 81 Issue 7, p2391-2402. 12p.
Database: Academic Search Ultimate
Description
ISSN:01054538
DOI:10.1111/all.70181